Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients
Journal of the Pediatric Infectious Diseases Society · 28.02.2024 · 13 (Supplement_1) · S14-S21
DOI: 10.1093/jpids/piad059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 28.02.2024. Verfasst von Kristen G Valencia Deray und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation, Acetates, Quinazolines. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Despite current prophylaxis regimens, cytomegalovirus (CMV) is common in hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) and remains a significant cause of morbidity and mortality. Newer antiviral medications are reshaping the landscape for prevention and treatment of CMV DNAemia, infection, and disease. Letermovir is approved for CMV prevention in adult HCT patients and is attractive due to the absence of marrow suppression seen with ganciclovir/valganciclovir. Letermovir should not be routinely used for CMV treatment due to its low threshold for resistance. Maribavir is approved for the treatment of refractory or resistant CMV disease in HCT and SOT recipients ≥12 years of age, though it has no current role in CMV prevention. More research is needed to fully elucidate the roles, efficacy, and safety of these newer agents in prevention and treatment of CMV in pediatric transplant recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
- Division of Infectious Disease, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
- Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Kristen G Valencia Deray, Kevin J Downes
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Valencia Deray, K. G., Danziger-Isakov, L. A., & Downes, K. J. (2024). Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients. Journal of the Pediatric Infectious Diseases Society, 13(Supplement_1), S14-S21. https://doi.org/10.1093/jpids/piad059
Vancouver
Valencia Deray KG, Danziger-Isakov LA, Downes KJ. Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients. Journal of the Pediatric Infectious Diseases Society. 2024;13(Supplement_1):S14-S21. doi:10.1093/jpids/piad059
BibTeX
@article{ValenciaDeray2024,
author = {Valencia Deray, Kristen G and Danziger-Isakov, Lara A and Downes, Kevin J},
title = {Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2024},
volume = {13},
number = {Supplement_1},
pages = {S14--S21},
doi = {10.1093/jpids/piad059}
}
EUVIMED